During the past decade, Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo" #1 sponsor was "Celgene" with 1 trials, followed by "European Myeloma Network" with 1 trials sponsored, "IRCCS Policlinico S. Matteo" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo" #1 collaborator was "Celgene Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo" are "Amyloidosis" (3 trials), "AL Amyloidosis" (1 trials), "Light-Chain Amyloidosis" (1 trials), "Lymphoma, Mantle-Cell" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo" in a lesser frequency.

Most popular intervention types in "Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (2 trials), "BMDex" (1 trials), "Bortezomib" (1 trials), "Cyclophosphamide" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo has several departments that took part in Clinical trials: "Cochin Hospital, Rheumatology department" - 3 trials